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increased from 3 day to 7 day in RVM as compared with sham
operated animals. However, the expression of GFAP (an astrocyte
marker) was not change in mirror image animal as compared with
sham control. Intra-RVM pretreatment of minocycline (microglia
inhibitor) or lidocaine exclusively inhibited contralateral allodynia
rather than ipsilateral allodynia. Moreover, same effective dose of
minocycline or lidocaine at mirror image pain did not modify the
mechanical allodynia in ipsilateral pain only animals.
Conclusions: These results suggest that contralateral mechanical
allodynia induced by SNL is associated with speciﬁc activation of
neuron and glial cell in RVM.
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Introduction: Unilateral nerve injury has been sometimes shown to
induce contralateral mechanical allodynia in a rat model, and this
phenomenon has been called “mirror-image pain”. However, the
mechanisms of mirror-image pain have not been well documented.
Objectives: Because spinal glial cells play an important role in the
initiation and maintenance of neuropathic pain, we investigated the
possible involvement of glial cells in mirror image pain.
Methods: Neuropathic pain was evoked by L5 spinal nerve ligation
(SNL) in rats.
Results: From 3 day to 7 days after SNL, mirror image pain
was evident about 30% of surgery rats. In mirror image pain
animals, the expression of CD11b (a microglia marker) and GFAP
(an astrocyte marker) was signiﬁcantly increased from 3 day to 7
day in the contralateral spinal dorsal horn as well as ipsilateral
spinal cord as compared with sham operated animals. Although
intrathecal pretreatment of minocycline (microglia inhibitor)
completely removed bilateral spinal CD11b elevation, it exclusively
inhibited contralateral allodynia at 3 day and 7 day after SNL
rather than ipsilateral allodynia. Moreover, intrathecal injection
of ﬂuorocitrate (astrocyte inhibitor) at 3 day after SNL failed to
decrease contralateral allodynia as well as ipsilateral allodynia,
but it showed signiﬁcant antinoceptive effect only in contralateral
allodynia at 7 days.
Conclusions: These results suggest that contralateral mechanical
allodynia induced by SNL is associated with speciﬁc activaiton of
glial cells in the contralateral spinal cord.
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Introduction: States of chronic neuropathic pain caused are
characterized by activation of microglia in the dorsal horn of spinal
cord and enhanced expression of transmembrane tumor necrosis
factor alpha (mTNFa).
Objectives: To determine the mechanisms responsible for
expression of mTNFa in microglia and the role of mTNFa signaling
in neuropathic pain.
Methods: We carried out a series of studies with immortalized
microglial (HAPI) cells in vitro.
Results: We found that:
1. HAPI cells express the full-length NK1 receptor, as well as TNFR1
and TNFR2;
2. HAPI cells are activated by LPS in induce expression of TNFa
and TACE, and rlease sTNFa and MCP-1 in a manner identical to
primary microglia;
3. Exposure to substance P increases expression of mTNF through
activation of PI3K-AKT but does not induce TACE or increase
release of sTNF;
4. TACE is requred for the release of sTNFa, and knocking down TACE
by siRNA enhances accumulation of mTNFa, as does treatment
with the TACE inhibitor TAPI-2;
5. mTNF a expressing cells activate microglia through cell-cell
contact, measured by increased expression of OX-42 and release
of MCP-1;
6. Recombinant mTNFa protein increases TNF but not TACE in
microglia;
7. Cells that overepxress mTNFa in the membrane assume a stellate
morphology.
Conclusions: SP increases expression of mTNFa in microglia, and
mTNFa activates microglia though cell-cell contact. Taken together
these results suggest the existence of a feed-forward mechanism
trigered by SP release that may be important in the transition from
acute to chronic pain.
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Introduction: Botulinum neurotoxin serotype A (BoNT/A) relieves
neuropathic pain symptoms, however the mechanism still remains
unclear.
Objectives: Descovering the potential mechanism of action of
BoNT/A after chronic constriction injury (CCI) of the sciatic nerve
in rat.
Methods:Wemeasured neuropathic pain using behavioral tests and
mRNA levels of neuropeptides, synaptosomal-associated protein-
25 (SNAP-25), neuronal (NOS1) and inducible (NOS2) nitric oxide
synthases as well as microglial (C1q) and astroglial (GFAP) markers
using competitive RT-PCR – according to IASP rules.
Results: In the lumbar spinal cord of CCI-exposed rats the
ipsilateral upregulation of prodynorphin, SNAP-25 and C1q
and no changes in NOS1, NOS2, GFAP, proenkephalin and
pronociceptin mRNAs were observed. In DRG the ipsilateral
upregulation of prodynorphin, pronociceptin, NOS1, NOS2, C1q and
GFAP mRNAs and, in contrast, downregulation of proenkephalin
and no changes in SNAP-25 mRNAs were observed. A single
intraplantar administration of BoNT/A (75pg/paw) induced long-
lasting antiallodynic/antihyperalgesic effects, which are paralleled
by reduced prodynorphin, pronociceptin, NOS1 mRNAs upregulation
in DRG together with signiﬁcant decrease of C1q-positive cells and
SNAP-25 mRNA upregulation, both in spinal cord and DRG. No
changes were observed for GFAP mRNA both in spinal cord and
DRG.
Conclusions: We provide evidence that BoNT/A not only
relieves neuropathic pain behavior, but also attenuates
microglial/macrophage and SNAP-25 activation in the spinal cord
and DRG and NOS1, prodynorphin and pronociceptin mRNAs level
increase in DRG. These results indicate the possible mechanism of
long-lasting effects of BoNT/A in neuropathic pain.
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